byiShook Opinion
Sep 3, 2024 - 10:00
Vaxcyte shares rocketed Tuesday after the biotech company delivered "stunning" test results for its pneumococcal vaccine. The post Vaxcyte Catapults 34% As It Looks To Take On Pfizer In A $10 Billion Market appeared first on Investor's Business Daily.
Vaxcyte shares rocketed Tuesday after the biotech company delivered "stunning" test results for its pneumococcal vaccine.
The post Vaxcyte Catapults 34% As It Looks To Take On Pfizer In A $10 Billion Market appeared first on Investor's Business Daily.